Janet Baer, MD | |
1493 Cambridge St, Radiology Department, Cambridge, MA 02139-1047 | |
(617) 665-1240 | |
Not Available |
Full Name | Janet Baer |
---|---|
Gender | Female |
Speciality | Radiology - Diagnostic Radiology |
Location | 1493 Cambridge St, Cambridge, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265427074 | NPI | - | NPPES |
3056660 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 54750 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Janet Baer, MD 1493 Cambridge St, Radiology Department, Cambridge, MA 02139-1047 Ph: (617) 665-1240 | Janet Baer, MD 1493 Cambridge St, Radiology Department, Cambridge, MA 02139-1047 Ph: (617) 665-1240 |
News Archive
Long-term use of a drug combination reduces the risk of recurrent urinary tract infection by up to 80 percent in children with the urinary condition vesicoureteral reflux compared to placebo, according to research funded by the National Institutes of Health.
Federal Drug Administration Commissioner Margaret A. Hamburg announced a new "Safe Use" program for drugs on Wednesday.
Many discoveries are made by chance, but it is also possible to help it along: The chance of finding something interesting increases when the number of experiments rises. French researchers have now applied this principle to the search for new chemical reactions. In the journal Angewandte Chemie, they have introduced a new concept based on antibodies and a "sandwich" immunoassay.
Remarkably, scientists are still debating just how to reliably determine whether someone is conscious. This question is of great practical importance when making medical decisions about anesthesia or treating patients in vegetative state or coma.
CoLucid Pharmaceuticals, Inc.,, an innovative biotechnology company focusing on therapies for central nervous system disorders, today announced that its investigational first-in-class Neurally Acting Anti-Migraine Agent (NAAMA), lasmiditan (also known as COL-144), a selective 5-HT1F receptor agonist, was effective when given orally to treat acute migraine attacks, as documented in a Phase IIb study.
› Verified 7 days ago
Donald Francis Romanelli, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn Street, Mount Auburn Hospital, Cambridge, MA 02138 Phone: 617-492-3500 | |
Dr. Carolyn Lamb, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Wyman 3, Cambridge, MA 02138 Phone: 617-499-5639 Fax: 617-499-5464 | |
Edward B Marianacci, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5070 Fax: 617-499-5138 | |
James J Pollard, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Radiology, Cambridge, MA 02139 Phone: 617-665-1298 | |
Adam F Gustin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Radiology Department, Cambridge, MA 02139 Phone: 617-665-1240 | |
Hyewon Hyun, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5070 Fax: 617-499-5138 | |
Nazli Erbay, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1599 |